Zhongchao Inc (ZCMD) Stock Analysis
Verdict: AVOID
Severe revenue contraction and chronic operating loss overshadow balance sheet cash, making ZCMD a speculative value trap.
Investment score: 21/100
Analysis as of
Is Zhongchao Inc stock worth reviewing? The TradeMates thesis
Zhongchao Inc is a micro-cap Chinese healthcare information provider suffering from a 28.3% top-line revenue decline, deep operating losses (-54.43% margin), and severe share price destruction (-99.9% off 52-week high).
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 30/100 (weight 15%)
- Technical Momentum: 10/100 (weight 15%)
- Earnings Quality: 15/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 20/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Zhongchao Inc opportunities and risks
What speaks for ZCMD
- Negative Enterprise Value / Cash Cushion ($8.10M Cash vs $5.34M Market Cap)
What speaks against ZCMD
- Accelerating Revenue Contraction (-28.3% YoY in 2025)
Peers and competitors
- JDZG
- YQ
- EDTK
- NAMI
- WAFU
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ZCMD | n/a | 0.0x | 1.5x | 43.8% | -55.5% | 2576.4% |
| JDZG | n/a | 0.7x | n/a | 37.0% | -41.2% | -169.0% |
| YQ | n/a | 0.9x | 2.0x | 61.2% | -46.4% | 12.7% |
| EDTK | n/a | 1059.5x | n/a | -802.4% | -60136.2% | -8.7% |
| NAMI | n/a | 0.1x | n/a | 11.0% | -22.8% | -54.0% |
| WAFU | n/a | 1.0x | 3.2x | 29.1% | -17.4% | -22.1% |
| Peer median | n/a | 0.9x | n/a | 29.1% | -41.2% | -22.1% |
Frequently asked questions about Zhongchao Inc (ZCMD)
Is ZCMD stock a good investment?
The TradeMates model rates Zhongchao Inc as AVOID with an investment score of 21/100. Zhongchao Inc is a micro-cap Chinese healthcare information provider suffering from a 28.3% top-line revenue decline, deep operating losses (-54.43% margin), and severe share price destruction (-99.9% off 52-week high). This is algorithmic model output, not personal investment advice.
Is ZCMD stock a buy?
The TradeMates model verdict for ZCMD is AVOID with an investment score of 21/100. Treat this as a model signal to review, not a personal buy recommendation.